CATALYST PHARMACEUTICAL PARTNERS, INC. 4
4 · CATALYST PHARMACEUTICAL PARTNERS, INC. · Filed Oct 20, 2014
Insider Transaction Report
Form 4
Winship M Douglas
V.P. of Regulatory Operations
Transactions
- Exercise/Conversion
Common stock, par value $0.001 per share
2014-10-17$0.90/sh+125,000$112,500→ 142,294 total - Tax Payment
Common stock, par value $0.001 per share
2014-10-17−45,363→ 96,931 total - Exercise/Conversion
Options to purchase common stock
2014-10-17−125,000→ 297,500 totalExercise: $0.90Exp: 2014-10-20→ Common Stock (125,000 underlying)
Footnotes (2)
- [F1]Holder exercised 125,000 options at $0.90 per share on a cashless basis and was issued 79,637 shares based on the October 17, 2014 closing price of $2.48 per share.
- [F2]The option was granted on October 20, 2009 and vested in three equal annual installments.